Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain (IDN5243inLBP)

Clinical Trial ID NCT02568826

Rank	Title	Journal	Year	PubWeight™‹?›
1	Measurement of pain.	Lancet	1974	15.02
2	Graphic representation of pain.	Pain	1976	14.25
3	Expenditures and health status among adults with back and neck problems.	JAMA	2008	6.11
4	A systematic review of low back pain cost of illness studies in the United States and internationally.	Spine J	2007	6.01
5	Pain: a review of three commonly used pain rating scales.	J Clin Nurs	2005	5.86
6	Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline.	Ann Intern Med	2007	3.27
7	The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.	Spine (Phila Pa 1976)	2012	1.92
8	Costs of back pain in Germany.	Eur J Pain	2008	1.75
9	The muscle relaxant thiocolchicoside is an antagonist of GABAA receptor function in the central nervous system.	Neuropharmacology	2006	1.05
10	Skeletal muscle relaxant use in the United States: data from the Third National Health and Nutrition Examination Survey (NHANES III).	Spine (Phila Pa 1976)	2004	0.97
11	The use of muscle relaxant medications in acute low back pain.	Spine (Phila Pa 1976)	2004	0.79
12	Use of medications in the treatment of acute low back pain.	Clin Occup Environ Med	2006	0.77
13	[Modern muscle relaxants and their clinical application].	Anaesthesist	1994	0.75